Talimogene Laherparepvec (T-VEC)

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Talimogene Laherparepvec (T-VEC)
Treatment and conditionWhere it standsTrials
Talimogene Laherparepvec (T-VEC) for carcinoma, squamous cellPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1